-
March 26: The Week in Cancer News
Underrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and a study provides new insight into how melanoma metastasizes.
by Bradley Jones
-
March 19: The Week in Cancer News
A study indicates breast cancer centers often recommend earlier and more frequent screening than national guidelines, and experts ponder COVID-19 vaccines' role is quelling the evolution of concerning viral variants in people with weakened immune systems.
by Marci A. Landsmann
-
March 12: The Week in Cancer News
Lung cancer screening recommendations expand to include more smokers, and a U.K. study finds cancer patients may be less protected from COVID-19 than people without cancer after the first dose of the Pfizer-BioNTech vaccine.
by Kevin McLaughlin
-
March 5: The Week in Cancer News
A patient advocate and researcher argue that the U.S. has set insufficiently ambitious cervical cancer screening goals, and Merck withdraws the small cell lung cancer indication for its immunotherapy drug Keytruda.
by Kate Yandell
-
February 26: The Week in Cancer News
Nonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.
by Bradley Jones
-
February 19: The Week in Cancer News
Organizations call to prioritize cancer patients for COVID-19 vaccination, researchers analyze rates of “low-value” breast surgeries, and UCLA cancer survivors write letters to patients undergoing treatment.
by Marci A. Landsmann
-
February 12: The Week in Cancer News
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and physicians warn that enlarged lymph nodes after COVID-19 vaccination can be mistaken for signs of breast cancer.
by Kate Yandell
-
February 5: The Week in Cancer News
Fecal transplants may improve immunotherapy responses, and more than half of cancer survivors have at least one additional condition that increases their risk of severe COVID-19.
by Kevin McLaughlin
-
January 29: The Week in Cancer News
Advocates are asking that cancer patients be prioritized for COVID-19 vaccination, and a KRAS inhibitor shows promising phase II trial results.
by Kate Yandell
-
January 22: The Week in Cancer News
Research measures regret about treatment among African Americans with prostate cancer, and COVID-19 vaccination recommendations for cancer patients are released.
by Marci A. Landsmann
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles